Cantor Fitzgerald Initiates Coverage On ProMIS Neurosciences with Overweight Rating
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsInitiation
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Overweight rating.
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Overweight rating.